[{"orgOrder":0,"company":"Johnson & Johnson","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Undisclosed","graph2":"Phase IV","graph3":"Johnson & Johnson","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Paste","sponsorNew":"Johnson & Johnson \/ Inapplicable","highestDevelopmentStatusID":"11","companyTruncated":"Johnson & Johnson \/ Inapplicable"},{"orgOrder":0,"company":"Universiti Sains Malaysia","sponsor":"3M ESPE | SDI Limited","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Universiti Sains Malaysia","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Topical","sponsorNew":"Universiti Sains Malaysia \/ 3M ESPE | SDI Limited","highestDevelopmentStatusID":"11","companyTruncated":"Universiti Sains Malaysia \/ 3M ESPE | SDI Limited"},{"orgOrder":0,"company":"Dr. D. Y. Patil Dental College & Hospital","sponsor":"Jasberry Healthcare","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Phase III","graph3":"Dr. D. Y. Patil Dental College & Hospital","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"Dr. D. Y. Patil Dental College & Hospital \/ Jasberry Healthcare","highestDevelopmentStatusID":"10","companyTruncated":"Dr. D. Y. Patil Dental College & Hospital \/ Jasberry Healthcare"},{"orgOrder":0,"company":"Indiana University","sponsor":"Haleon","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Phase III","graph3":"Indiana University","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indiana University \/ Haleon","highestDevelopmentStatusID":"10","companyTruncated":"Indiana University \/ Haleon"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Phase III","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Colgate Palmolive \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"Colgate Palmolive \/ Inapplicable"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Other Small Molecule","year":"2025","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Phase II","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PROCTER AND GAMBLE \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"PROCTER AND GAMBLE \/ Inapplicable"},{"orgOrder":0,"company":"Protegera Inc","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Phase I","graph3":"Protegera Inc","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"Protegera Inc \/ Inapplicable","highestDevelopmentStatusID":"6","companyTruncated":"Protegera Inc \/ Inapplicable"},{"orgOrder":0,"company":"Haleon","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Undisclosed","graph3":"Haleon","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Strip","sponsorNew":"Haleon \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Haleon \/ Inapplicable"}]

Find Clinical Drug Pipeline Developments & Deals for Fluonatril

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          CPhI Korea
                          Not Confirmed
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 25, 2025

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          CPhI Korea
                          Not Confirmed
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          July 05, 2024

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          CPhI Korea
                          Not Confirmed
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          November 29, 2023

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Protegera Inc

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Protegera Inc

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          October 13, 2023

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Indiana University

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Indiana University

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 25, 2023

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase III

                          Sponsor : Haleon

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Dr. D. Y. Patil Dental College & Hospital

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Dr. D. Y. Patil Dental College & Hospital

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          May 10, 2023

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase III

                          Sponsor : Jasberry Healthcare

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          Universiti Sains Malaysia

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Universiti Sains Malaysia

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 16, 2023

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : 3M ESPE | SDI Limited

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          CPhI Korea
                          Not Confirmed
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 06, 2023

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase IV

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          Domenick Zero

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Domenick Zero

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          December 26, 2017

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase III

                          Sponsor : GSK

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          CPhI Korea
                          Not Confirmed
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          September 28, 2017

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank